BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
26 oct. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Oct. 26, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTC PINK: BSEM), a leading regenerative medicine company focused on the development,...
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
10 oct. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Oct. 10, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC PINK: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts
13 sept. 2022 07h30 HE
|
BioStem Technologies, Inc.
Standardized methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje® and Vendaje AC® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE...
BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe
08 sept. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Reports Second Quarter 2022 Operating and Financial Results
22 août 2022 16h01 HE
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on August 22, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Aug. 22, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
BioStem Technologies to Host Second Quarter Financial Results and Corporate Update Conference Call on August 22nd
16 août 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies® CEO to Appear on the Benzinga All Access Show on June 17,2022
17 juin 2022 09h25 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development,...
BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results
16 mai 2022 12h25 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., May 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Inc. Reports December 31, 2021 Year End Financial Results
01 avr. 2022 10h00 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., April 01, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Announces Veterans Day Fundraiser to Support America's VetDogs®
01 nov. 2021 09h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, Fl., Nov. 01, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. and its subsidiary Blue Tech Industries, Inc. (d/b/a BioStem Life Sciences), a Certified VOSB (Veteran-Owned Small...